Navigation Links
Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
Date:9/4/2007

Toronto, ON (September 4, 2007) The results of a clinical trial, published in late August in the Journal of Pediatrics, indicates that, when used as part of routine therapy, high-dose ibuprofen is safe, and effective in slowing down lung disease in children with cystic fibrosis (CF).

Headed by Dr. Larry Lands, Director of Pediatric Respiratory Medicine at Montreal Childrens Hospital of the McGill University Health Centre, the multi-centre study monitored 142 children aged six to 18 with mild lung disease over two years.

Children given high-dose ibuprofen twice a day showed a significant reduction in the rate of decline in lung function, and had fewer and shorter hospital stays.

Slowing the rate of the decline of lung function will result in enhanced longevity and quality of life for patients with CF, said Dr. Larry Lands.

Many treatments for cystic fibrosis can be a financial hardship for families, said Cathleen Morrison, Chief Executive Officer at the Canadian Cystic Fibrosis Foundation. News that ibuprofen a relatively inexpensive treatment compared to other therapies for CF is effective, is very exciting.

"We are delighted to share this great news. The findings of this study show that through research and innovation, a simple inexpensive treatment can have a profound impact on the lives of children affected by CF and their families," said Dr. Peter Liu, Scientific Director of CIHR's Institute of Circulatory and Respiratory Health.


'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-934-1934
McGill University Health Centre
Source:Eurekalert

Page: 1

Related medicine news :

1. Ibuprofen weakens aspirins effect
2. Ibuprofen to lower risk of Parkinson’s diseas
3. Safest painkiller Ibuprofen found to cause severe GI bleeding
4. Use Of Ibuprofen Safe For Short Periods
5. Ibuprofen and Vitamins C and E Could Halt Alzheimers
6. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
7. Children Find Effective Pain Relief With Ibuprofen
8. Ibuprofen Risky for Heart Patients?
9. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
10. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
11. Vitamins-The answer to Heart Disease?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... New york (PRWEB) , ... April 28, 2017 ... ... pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice ... training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique ...
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... Linda, Ca (PRWEB) , ... April 28, 2017 ... ... with cardiac or hERG liability could substantially improve drug safety and minimize the ... be provided for validating ion channel inhibition using cell lines and for cardiac ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Bill Howe started ... in the coastal communities. After Tina Howe joined the team, the Bill Howe brand ... honest services at affordable rates, and giving back to the San Diego community in ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... are conducting a pilot study of ActiGraph’s CentrePoint Data Hub in ... a leading provider of clinical-grade wearable activity and sleep monitoring solutions for the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
Breaking Medicine Technology: